Melanoma Clinical Trials in Washington

Showing 121-127 of 127 trials

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

The purpose of this clinical trial is to determine if Allovectin-7®, an experimental gene-based immunotherapy, can shrink melanoma tumors. The trial will also examine if this treatment can improve the time to disease progression.

MelanomaMetastatic MelanomaMalignant Melanoma+1 more

Vical133 participantsStarted Feb 2001

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Bakersfield, California, United States +13 more locations

COMPLETEDPhase 142 miles

Biological Therapy in Treating Patients With Metastatic Melanoma

NCT00045149

RATIONALE: Biological therapies such as cellular adoptive immunotherapy use different ways to stimulate the immune system and stop cancer cells from growing. Treating a person's white blood cells in the laboratory and then reinfusing them may cause a stronger immune response and kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of biological therapy in treating patients who have metastatic melanoma.

Melanoma (Skin)

Fred Hutchinson Cancer CenterStarted Oct 2002

Seattle, Washington, United States

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Biological Therapy in Treating Patients With Metastatic Melanoma

Melanoma Trials in Other Cities

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Other Conditions in Washington